EAM
REGN icon

Empirical Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Empirical Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-407
Closed -$392K – 379
2024
Q1 		$392K Buy
407
+61
+18% +$58K 0.19% 154
2023
Q4 		$304K Sell
346
-749
-68% -$617K 0.25% 134
2023
Q3 		$901K Buy
1,095
+110
+11% +$86.5K 0.79% 33
2023
Q2 		$708K Buy
985
+55
+6% +$42.4K 0.63% 53
2023
Q1 		$764K Buy
930
+237
+34% +$179K 0.73% 46
2022
Q4 		$500K Sell
693
-339
-33% -$250K 0.53% 76
2022
Q3 		$711K Buy
1,032
+348
+51% +$219K 0.78% 38
2022
Q2 		$404K Buy
+684
New +$445K 0.43% 84

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return